Cardiopulmonary disease - information, support and reception
11 – 20 of 117
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis
- Contribution to journal › Article
-
Mark
Right ventricular dyssynchrony predicts outcome in pulmonary arterial hypertension when assessed in multiple cardiac magnetic resonance views
- Contribution to journal › Article
-
Mark
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10–12 Years After Heart Transplantation : The Results of a Randomized Controlled Trial (SCHEDULE Trial)
- Contribution to journal › Article
-
Mark
Risk stratification and treatment goals in pulmonary arterial hypertension
- Contribution to journal › Scientific review
-
Mark
Right ventricular stroke work index from echocardiography in patients with pulmonary arterial hypertension-the role in short-term follow-up assessment
- Contribution to journal › Article
-
Mark
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
- Contribution to journal › Article
-
Mark
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota
- Contribution to journal › Article
-
Mark
Change in health-related quality of life at early follow-up in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
- Contribution to journal › Article
-
Mark
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis
- Contribution to journal › Article
-
Mark
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions
- Contribution to journal › Scientific review
